Teva- Pharmaceutical Industries (TEVA) P/E (2017 - 2026)
Teva- Pharmaceutical Industries (TEVA) P/E from Mar 31, 2017 to Jun 3, 2026. The TTM Teva- Pharmaceutical Industries (TEVA) P/E is 29.04. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Teva- Pharmaceutical Industries (TEVA)
| Year | P/E | Change |
|---|---|---|
| 2026 | 29.04 | -60.39% |
| 2025 | 73.31 | -497.37% |
| 2024 | -18.45 | +52.67% |
| 2023 | -12.08 | +0.25% |
| 2022 | -12.05 | +418.54% |
| 2021 | -2.32 | -2.08% |
| 2020 | -2.37 | -70.47% |
| 2019 | -8.04 | -170.22% |
| 2018 | 11.45 | -399.18% |
| 2017 | -3.83 | N/A |
Comparison Teva- Pharmaceutical Industries (TEVA) P/E with competitors
Teva- Pharmaceutical Industries (TEVA) P/E is 29.04.